1.80
10.89%
-0.22
After Hours:
1.65
-0.15
-8.33%
Conduit Pharmaceuticals Inc stock is currently priced at $1.80, with a 24-hour trading volume of 109.37K.
It has seen a -10.89% decreased in the last 24 hours and a -36.62% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $2.36 pivot point. If it approaches the $1.60 support level, significant changes may occur.
Previous Close:
$2.02
Open:
$1.91
24h Volume:
109.37K
Market Cap:
$132.89M
Revenue:
-
Net Income/Loss:
$-4.21M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-36.62%
1M Performance:
-36.62%
6M Performance:
-74.79%
1Y Performance:
+0.00%
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
Name
Conduit Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
89 Nexus Way, Grand Cayman
Conduit Pharmaceuticals Inc Stock (CDT) Latest News
Presidio Property Trust (NASDAQ:SQFT) vs. Ventas (NYSE:VTR) Critical Survey - Defense World
Defense World
Market Movers Blog: Apple teams up with OpenAI to launch AI-backed 'Apple Intelligence' - Investment Week
Investment Week
Market Movers Blog: Apple teams up with OpenAI to launch AI-backed 'Apple Intelligence' - Investment Week
Investment Week
Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update - Defense World
Defense World
ING Groep (NYSE:ING) Short Interest Update - Defense World
Defense World
Plasma Protease C1-inhibitor Market Analysis and Revenue Prediction | KalVista Pharmaceuticals, Inc., CSL Behring ... - Weekly Post Gazette
Weekly Post Gazette
Conduit Pharmaceuticals Inc Stock (CDT) Financials Data
Conduit Pharmaceuticals Inc (CDT) Net Income 2024
CDT net income (TTM) was -$4.21 million for the quarter ending September 30, 2023.
Conduit Pharmaceuticals Inc (CDT) Earnings per Share 2024
CDT earnings per share (TTM) was -$0.0548 for the quarter ending September 30, 2023.
About Conduit Pharmaceuticals Inc
Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
Cap:
|
Volume (24h):